In PepBank now:147 peptides, 6 blends and 13 other compounds97,577 study results from 17,383 studies8,473 clinical trialsUpdated
PepBank shows no results on Cathelicidin antimicrobial peptide precursor (hCAP18) from studies in people, animals, the lab or computer predictions. Data as of 2026-10-30.
Also known as CAMP, CAP18, FALL39, hCAP-18, hCAP18, Cathelicidin antimicrobial peptide
| What it is | Natural peptide, 170 amino acids |
|---|---|
| Approval | Not approved for any use |
| In sport | Not named on the List; S0 may still apply (no approval anywhere) |
| Studies | No study results for Cathelicidin antimicrobial peptide precursor (hCAP18) yet |
| Clinical trials | None registered |
Human cathelicidin precursor protein (gene CAMP). Processing releases LL-37 and other antimicrobial peptides.
Amino acids in one chain
The key facts about the molecule. Long codes are in the closed section below.
Curo is a peptide shop. PepBank and Curo have the same owner. See the Curo catalog (opens in a new tab).
Results grouped by what the studies measured. Each card shows where its results come from.
No approved medicine contains it.
No approved medicine contains it.
Not named on the List. Section S0 covers substances with no approval.
No. Not approved for any use. The sources we use show no clinical development. They show no approval at the FDA, the EMA or elsewhere (as of 8 Oct 2026). Not named on the List; S0 may still apply (no approval anywhere).
Laws and labels change, so check the regulator for the current status.
PepBank has no safety result from studies of Cathelicidin antimicrobial peptide precursor (hCAP18) yet. That does not mean Cathelicidin antimicrobial peptide precursor (hCAP18) is safe.
The answer links to every study it uses.
AI wrote and checked these results. AI can make mistakes, so check important results against the source.
PepBank is a research reference. Talk to a doctor before you use any peptide.